1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 3 ALCANZA study of brentuximab vedotin (BV) or physician's choice (PC) of methotrexate (MTX) or bexarotene (Bex) in CD30-positive cutaneous T-cell lymphoma (CTCL): Number needed to treat analysis
    Meeting Abstract

    Zagadailov, E.; Prince, H. M.; Whittaker, S.; Horwitz, S.; Duvic, M.; Kim, Y.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Prognostic tools can provide personalized outcomes prediction after allogeneic HCT in patients with hematologic malignancies
    Meeting Abstract

    Cho, C.; Devlin, S.; Hilden, P.; Maloy, M.; Horowitz, M.; Rizzo, J. D.; Logan, B.; Barba, P.; O'Reilly, R.; Giralt, S.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Improved survival in 21,465 multiple myeloma patients: Results from a population-based study
    Meeting Abstract

    Thorsteinsdottir, S.; Dickman, P. W.; Turesson, I.; Landgren, O.; Hultcrantz, M.; Björkholm, M.; Kristinsson, S. Y.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Risk of thrombosis in patients with non-Hodgkin's lymphoma: A population-based cohort study
    Meeting Abstract

    Birgisdóttir, A. M.; Sverrisdottir, I. S.; Landgren, O.; Björkholm, M.; Kristinsson, S. Y.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Cytosolic nucleic acid sensors promote intestinal epithelial integrity during acute tissue damage and protect from graft-versus-host disease
    Meeting Abstract

    Fischer, J. C.; Eisenkolb, G.; Bscheider, M.; Wintges, A.; Peschel, C.; Lindemans, C. A.; Hanash, A. M.; Jenq, R.; Dudakov, J.; Haas, T.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Nivolumab for relapsed/refractory classical Hodgkin lymphoma after autologous transplant: Full results after extended follow-up of the multicohort multicenter phase 2 CheckMate 205 trial
    Meeting Abstract

    Engert, A.; Fanale, M.; Santoro, A.; Armand, P.; Ansell, S.; Zinzani, P. L.; Timmerman, J.; Collins, G.; Ramchandren, R.; Cohen, J.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma or diffuse large B-cell lymphoma: Updated results of a Phase 1b/2 study
    Meeting Abstract

    Matasar, M.; Herrera, A. F.; Kamdar, M.; Mehta, A.; Assouline, S.; Fleury, I.; Kim, T. M.; Kim, W. S.; Bosch, F.; Radford, J.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Differentiation syndrome associated with enasidenib (AG-221), a selective inhibitor of mutant isocitrate dehydro-genase 2 (mIDH2)
    Meeting Abstract

    Fathi, A. T.; DiNardo, C. D.; Kline, I.; Kenvin, L.; Gupta, I.; Attar, E. C.; Stein, E. M.; de Botton, S.
    Haematologica (2017)

    Fulltext@MSK | Save
  • AICDA drives epigenetic heterogeneity in germinal center-derived lymphomas and accelerates lymphomagenesis
    Meeting Abstract

    Dominguez, P. M.; Teater, M.; Redmond, D.; Chen, Z.; Ennishi, D.; Scott, D. W.; Cimmino, L.; Ghione, P.; Chaudhuri, J.; Gascoyne, R. D.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia: Initial results from the BFORE trial
    Meeting Abstract

    Brümmendorf, T. H.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Reilly, L.; Jeynes-Ellis, A.; Leip, E.; Bardy-Bouxin, N.; more...
    Haematologica (2017)

    Fulltext@MSK | Save